Quick Answer
HeartSciences Inc. reported Earnings Per Share Diluted of $9.34 (loss) per share for the year ending 2025.
- HeartSciences Inc. showed an increase of +50.2% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from HeartSciences Inc.'s annual report (Form 10-K), filed with the SEC on July 24, 2025.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2021: $0.15 (loss) per share | Q4 2021: $0.31 (loss) per share | Q1 2022: $0.37 (loss) per share | Q3 2022: $0.28 (loss) per share | Q4 2022: $0.22 (loss) per share | Q1 2023: $0.16 (loss) per share | Q3 2023: $13.23 (loss) per share | Q4 2023: $15.92 (loss) per share | Q1 2024: $3.01 (loss) per share | Q3 2024: $2.64 (loss) per share | Q4 2024: $2.27 (loss) per share | Q1 2025: $2.57 (loss) per share | Q3 2025: $1.58 (loss) per share | Q4 2025: $0.85 (loss) per share.
- Over the full 4 years of available data (2022 to 2025), HeartSciences Inc.'s Earnings Per Share Diluted has declined by 544.1%.
- Historical annual values: Fiscal year 2025: $9.34 (loss) per share | Fiscal year 2024: $18.74 (loss) per share | Fiscal year 2023: $80.00 (loss) per share | Fiscal year 2022: $1.45 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: